The Valley Desk

NCT06305767 · Interventional trial

A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Bladder Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov